- Home
- SOPH vs SABA Comparison
SOPH vs SABA Comparison
Compare SOPH & SABA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SOPH | SABA |
|---|---|---|
| Founded | 2011 | 1988 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 462.3M | 221.3M |
| IPO Year | 2021 | 1994 |
Fundamental Metrics
Financial Performance| Metric | SOPH | SABA |
|---|---|---|
| Price | $8.34 | $8.05 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $7.50 | N/A |
| AVG Volume (30 Days) | ★ 624.7K | 56.5K |
| Earning Date | 05-05-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 12.91% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $23.09 | N/A |
| Revenue Next Year | $19.57 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.75 | $7.80 |
| 52 Week High | $8.98 | $9.18 |
Technical Indicators
Market Signals| Indicator | SOPH | SABA |
|---|---|---|
| Relative Strength Index (RSI) | 57.08 | 42.25 |
| Support Level | $4.63 | $7.97 |
| Resistance Level | $8.84 | $8.40 |
| Average True Range (ATR) | 0.40 | 0.09 |
| MACD | -0.04 | -0.01 |
| Stochastic Oscillator | 68.38 | 33.76 |
Price Performance
Historical ComparisonAbout SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.
About SABA Saba Capital Income & Opportunities Fund II Shares of Beneficial Interest
Saba Capital Income & Opportunities Fund II is a closed-end fund. The company seeks high current income, with a secondary goal of capital appreciation. The fund invests in fixed income markets across the globe.